
Aster DM Quality Care Commences Operations With 39 Hospitals Across 28 Cities
Aster DM Quality Care Limited today commenced operations following the successful completion of the merger between Aster DM Healthcare and Quality Care India Limited (QCIL). This new entity brings together four leading healthcare brands: Aster DM, CARE Hospitals, Evercare, and KIMSHEALTH. The merger aims to create a strong platform dedicated to expanding access to world class healthcare by integrating specialist expertise, advanced treatment, and cutting edge medical technology closer to patients across India.The combined organization is positioned to hold a significant presence in several fast growing healthcare centers beyond major metropolitan areas. Aster DM Quality Care plans to decentralize affordable and advanced healthcare by expanding specialist services and investing in crucial technologies in these emerging centers.
Operational Scale and Strategy
With 39 hospitals spanning 28 cities, the company currently operates over 10,600 beds. These operations are strategically focused on serving tier two and tier three cities across India, including locations such as Nagpur, Aurangabad, Vijayawada, Guntur, Bhubaneswar, Raipur, Nagercoil, Kolhapur, Kannur, Kasaragod, and Kottakkal.The commitment extends to advanced healthcare capabilities. The group is expanding beyond its current infrastructure by accelerating investments in technologies like Gamma Knife, stereotactic radiosurgery systems (such as ZAP), 10 robotic surgical platforms, and other next generation clinical capabilities. Furthermore, the entity is adding 12 LINAC based radiation therapy systems across tier two and tier three cities to make advanced cancer care more accessible.
The combined bed strength of Aster DM Quality Care is expected to grow to over 15,000 beds in the coming years. The organization also boasts a workforce exceeding 45,000 healthcare professionals, representing one of India's most extensive clinical ecosystems.
Focus on Integration and Patient Care
Dr Azad Moopen, Executive Chairman of Aster DM Quality Care, stated that the combination of Aster and Quality Care marks a defining milestone in building one of India’s trusted and future ready healthcare institutions. He emphasized that the merger represents a convergence of shared values, clinical excellence, deep medical expertise, and an unwavering commitment to patient care, creating an institution that is stronger and better positioned to address evolving healthcare needs.Mr Varun Khanna, Managing Director and Group CEO, highlighted the complementary nature of the combined institutions. He stated that Aster Quality Care will place patients and their families at the center of every decision, using digitally enabled solutions and focusing on high quality clinical outcomes. Immediate priorities include disciplined and seamless integration while ensuring continuity of patient care across the merged network.
The operational commitment involves delivering comprehensive healthcare services across primary, secondary, tertiary, and quaternary levels. The integrated platform covers key specialties including oncology, cardiac sciences, neurosciences, gastro sciences, orthopaedics, nephrology, organ transplantation, mother and child care, and critical care.
Combined Entity Overview
Aster DM Quality Care Limited is formed through the merger of Aster DM Healthcare Limited and Quality Care India Limited. The new entity maintains a strong footprint across South and Central India.Key operational statistics for the combined enterprise are presented below:
| Metric | Detail |
|---|---|
| Number of Hospitals | 39 |
| Cities Covered | 28 |
| Current Bed Strength | Over 10,600 beds |
| Professional Workforce | More than 45,000 |
| Future Growth Potential | Expected to exceed 15,000 beds |
ASTERDM Stock Price Movement
Shares of Aster DM Healthcare Limited are edging higher to ₹795 as of 1:41 PM today, having gained 2.45% in live trading. The stock sees strong intraday interest, with a total traded volume amounting to 263,311 shares so far.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.